| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| STRECK PAUL | EVP, Head of R&D | C/O PEPGEN INC., 321 HARRISON AVE., 8TH FL, BOSTON | /s/ Noel Donnelly, as attorney-in-fact | 02 Jun 2025 | 0001708063 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PEPG | Common Stock | Purchase | $10,393 | +8,375 | +43% | $1.24 | 27,805 | 30 May 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Shares of Common Stock purchased pursuant to the PepGen Inc. 2022 Employee Stock Purchase Plan ("ESPP"), for the purchase period of December 1, 2024 to May 30, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of PepGen's Common Stock on May 30, 2025. |